Altimmune Inc (ALT)

12.77
+0.15(+1.19%)
After Hours
12.72
-0.05(-0.39%)
- Real-time Data
  • Volume:
    1,266,535
  • Day's Range:
    12.58 - 13.40
  • 52 wk Range:
    3.83 - 23.49

ALT Overview

Prev. Close
12.62
Day's Range
12.58-13.4
Revenue
3.48M
Open
12.64
52 wk Range
3.83-23.49
EPS
-2.24
Volume
1,266,535
Market Cap
619.37M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
2,492,760
P/E Ratio
-
Beta
0.469
1-Year Change
12.91%
Shares Outstanding
48,501,594
Next Earnings Date
Mar 30, 2023
What is your sentiment on Altimmune?
or
Market is currently closed. Voting is open during market hours.

Altimmune Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Altimmune Inc Analysis

Altimmune Inc Company Profile

Altimmune Inc Company Profile

Employees
47

Altimmune, Inc. is a clinical-stage biopharmaceutical company that is focused on developing treatments for obesity and liver diseases. The Company’s lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and non-alcoholic steatohepatitis (NASH). It is also developing HepTcell, an immunotherapeutic agent designed to achieve a functional cure for chronic hepatitis B. The Company has initiated a Phase II clinical trial of HepTcell and are in Phase II and Phase I clinical development with pemvidutide for multiple indications. It is conducting its Phase II clinical trial of HepTcell in the United States, United Kingdom, Canada, Germany and Spain, and conducting Its pemvidutide Phase I clinical trial in Australia. Its wholly owned subsidiaries include Altimmune, LLC, Altimmune UK, Limited, Spitfire Pharma, LLC and Altimmune AU Pty, Limited.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellStrong SellSellNeutral
Technical IndicatorsNeutralStrong SellSellStrong SellStrong Buy
SummaryNeutralStrong SellStrong SellStrong SellBuy
  • Anyone around?
    0
    • I've seen this one before, it looks like a come back but when I buy it, it goes down to a dollar. I'm not buying it though so it will probably do great ;o)
      1
      • lol. i would recommend you buy the stock and put in a stop loss to limit the potential damage for a speculative stock like this. i believed in this comeback early, so i bought in a month ago at 9. its been a nice run. i am now expecting a little pause, so i may sell some short term calls to take in a little profit.
        0
    • What is the sxpectations ?
      0
      • https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
        0
        • check out RIGL
          0
          • 28?
            0
            • Great stock
              0
              • 20.000plz
                0
                • 20.000plz
                  0
                  • Wow 14.88
                    0